LETTER — Response to RFI on Reporting on Pharmacy Benefits and Prescription Drug Costs

In this letter, ACHP provides recommendations to the Biden Administration on how to improve the Requirements Related to Prescription Drug Reporting executive order. ACHP calls for explore reporting requirements for drug makers and streamlining the reporting process on pharmacy benefits.

Download Letter

Learn How ACHP is Working to Lower Drug Prices

Learn How ACHP is Fighting to Make Health Care better